These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8186501)

  • 1. Studies of protein bound substances in uremia.
    Vanholder R; De Smet R; Ringoir S
    ASAIO J; 1994; 40(1):90-2. PubMed ID: 8186501
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry.
    Cheng Y; Ho E; Subramanyam B; Tseng JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):67-73. PubMed ID: 15282095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of in vitro and in vivo solute-protein binding interactions in normal and uremic subjects.
    Farrell PC; Grib NL; Fry DL; Popovich RP; Broviac JW; Babb AL
    Trans Am Soc Artif Intern Organs; 1972; 18(0):268-76, 281. PubMed ID: 4679879
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of unbound drug concentration and protein-drug binding fraction in plasma.
    Liu Z; Li F; Huang Y
    Biomed Chromatogr; 1999 Jun; 13(4):262-6. PubMed ID: 10416057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of solid-phase microextraction in the investigation of protein binding of pharmaceuticals.
    Theodoridis G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):238-44. PubMed ID: 16298173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renal disease upon drug disposition.
    Reidenberg MM; Drayer DE
    Drug Metab Rev; 1978; 8(2):293-302. PubMed ID: 363386
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of drug-protein binding by immobilized human serum albumin-HPLC and comparison with ultrafiltration.
    Singh SS; Mehta J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):108-16. PubMed ID: 16567134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of pharmacokinetics in uremia with special reference to drug catabolism].
    Leber HW
    Med Klin; 1976 Aug; 71(34):1321-30. PubMed ID: 785180
    [No Abstract]   [Full Text] [Related]  

  • 9. Ligand binding to a human serum albumin stationary phase: use of same-drug competition to discriminate pharmacologically relevant interactions.
    Ascoli GA; Bertucci C; Salvadori P
    Biomed Chromatogr; 1998; 12(5):248-54. PubMed ID: 9787894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid-chromatographic profiling of endogenous fluorescent substances in sera and urine of uremic and normal subjects.
    Mabuchi H; Nakahashi H
    Clin Chem; 1983 Apr; 29(4):675-7. PubMed ID: 6831696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of glycosylation on the drug binding of human serum albumin.
    Koizumi K; Ikeda C; Ito M; Suzuki J; Kinoshita T; Yasukawa K; Hanai T
    Biomed Chromatogr; 1998; 12(4):203-10. PubMed ID: 9667024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization.
    Zhang J; Musson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 843(1):47-56. PubMed ID: 16815762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of renal failure on the frequency of undesirable drug effects].
    Ruiz I; Naranjo CA; Campillo G
    Therapie; 1977; 32(3):271-8. PubMed ID: 929498
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug therapy in renal failure.
    Reidenberg MM; Drayer DE
    Annu Rev Pharmacol Toxicol; 1980; 20():45-54. PubMed ID: 6992702
    [No Abstract]   [Full Text] [Related]  

  • 15. Similarity of the dialysance of endogenous aryl acids and O-iodohippurate (hippuran) in uremic man.
    Cohlmia JB; Whittier FC; Grantham JJ
    Proc Clin Dial Transplant Forum; 1974; (4):224-7. PubMed ID: 4468422
    [No Abstract]   [Full Text] [Related]  

  • 16. Distribution volume related to body weight and protein binding.
    Jusko WJ; Chiang ST
    J Pharm Sci; 1982 Apr; 71(4):469-70. PubMed ID: 7086663
    [No Abstract]   [Full Text] [Related]  

  • 17. Determination of human plasma protein binding of baicalin by ultrafiltration and high-performance liquid chromatography.
    Tang Y; Zhu H; Zhang Y; Huang C
    Biomed Chromatogr; 2006 Oct; 20(10):1116-9. PubMed ID: 16708379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective reversible binding properties of the glucuronide conjugates of fenoprofen enantiomers to human serum albumin.
    Bischer A; Iwaki M; Zia-Amirhosseini P; Benet LZ
    Drug Metab Dispos; 1995 Sep; 23(9):900-3. PubMed ID: 8565778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
    Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
    J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism.
    Ascoli GA; Domenici E; Bertucci C
    Chirality; 2006 Sep; 18(9):667-79. PubMed ID: 16823814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.